EC

electroCore, Inc.

ECORHealthcareNASDAQ

Medical Devices · Last scanned Oct 24, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$32.0M
+27.2% YoY
Net Income
-$14.0M
-17.5% YoY
EBITDA
-$11.7M
-13.2% YoY
Free Cash Flow
-$4.7M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▼ Below MA2000.1% below MA200
▲ RSI OversoldRSI 7.8, below 30, stock may be oversold
Oct 19CONFIRMED▲ RSI OversoldRSI 7.9, below 30, stock may be oversold
About electroCore, Inc.

Part of the healthcare sector, electroCore, Inc. (ECOR) is listed under Medical Devices. The $63.6M market capitalization puts ECOR squarely in micro-cap range for its industry. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.

Where ECOR stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, ECOR finished 5.10% below its 150-day moving average ($8.04) and 0.13% below its 200-day moving average ($7.64). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is ECOR overbought or oversold?

At the October 20, 2026 close, ECOR's RSI(14) was 7.8, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$63.6M
Fwd P/E-12.82
EPS$-1.61
Beta1.05
52W Change+41.6%
Dividend Yield0.00%
Analysis

electroCore, Inc. holds $10.0M in cash against $9.6M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company is burning cash, with free cash flow at -$4.7M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Revenue has grown from $8.6M (2022) to $32.0M (2025), reflecting a 273% increase over the period.

The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for electroCore, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms